Abstract
Importance of the field: Reactive oxygen species (ROS) occur as natural by-products of oxygen metabolism and have important cellular functions. Normally, the cell is able to maintain an adequate balance between the formation and removal of ROS either via anti-oxidants or through the use specific enzymatic pathways. However, if this balance is disturbed, oxidative stress may occur in the cell, a situation linked to the pathogenesis of many diseases, including cancer.Areas covered in this review: HDACs are important regulators of many oxidative stress pathways including those involved with both sensing and coordinating the cellular response to oxidative stress. In particular aberrant regulation of these pathways by histone deacetylases may play critical roles in cancer progression.What the reader will gain: In this review we discuss the notion that targeting HDACs may be a useful therapeutic avenue in the treatment of oxidative stress in cancer, using chronic obstructive pulmonary disease (COPD), NSCLC and hepatocellular carcinoma (HCC) as examples to illustrate this possibility.Take home message: Epigenetic mechanisms may be an important new therapeutic avenue for targeting oxidative stress in cancer.
Full Text
Topics from this Paper
Oxidative Stress In Cancer
Removal Of Reactive Oxygen Species
Oxidative Stress
Targeting Oxidative Stress
Chronic Obstructive Pulmonary Disease
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Cancer Research
Aug 1, 2015
Jan 1, 2022
Journal of Cellular and Molecular Medicine
Sep 1, 2009
Experimental Physiology
Mar 8, 2013
Cancers
Jun 21, 2021
Journal of Allergy and Clinical Immunology
Oct 1, 2019
International Journal of Cosmetic Science
Aug 28, 2021
Journal of Biological Chemistry
Jan 1, 2012
Jan 1, 2019
Trends in Pharmacological Sciences
Jul 1, 2017
Journal of Biological Chemistry
Dec 1, 2005
Expert Opinion on Therapeutic Targets
Expert Opinion on Therapeutic Targets
Dec 2, 2023
Expert Opinion on Therapeutic Targets
Dec 2, 2023
Expert Opinion on Therapeutic Targets
Nov 25, 2023
Expert Opinion on Therapeutic Targets
Nov 25, 2023
Expert Opinion on Therapeutic Targets
Nov 15, 2023
Expert Opinion on Therapeutic Targets
Nov 2, 2023
Expert Opinion on Therapeutic Targets
Nov 2, 2023
Expert Opinion on Therapeutic Targets
Nov 2, 2023
Expert Opinion on Therapeutic Targets
Nov 2, 2023
Expert Opinion on Therapeutic Targets
Nov 2, 2023